PASUT, GIANFRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.870
EU - Europa 1.508
AS - Asia 942
AF - Africa 14
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
Totale 12.343
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.846
IT - Italia 627
CN - Cina 617
FI - Finlandia 264
VN - Vietnam 229
DE - Germania 180
UA - Ucraina 136
SE - Svezia 96
GB - Regno Unito 83
FR - Francia 41
IN - India 26
CA - Canada 20
IE - Irlanda 20
TR - Turchia 18
IR - Iran 13
NL - Olanda 13
ES - Italia 10
PK - Pakistan 10
RU - Federazione Russa 10
EG - Egitto 8
GR - Grecia 8
KR - Corea 7
HK - Hong Kong 6
SG - Singapore 5
JP - Giappone 4
AT - Austria 3
CR - Costa Rica 3
PT - Portogallo 3
ZA - Sudafrica 3
A1 - Anonimo 2
AU - Australia 2
BE - Belgio 2
CH - Svizzera 2
NZ - Nuova Zelanda 2
PL - Polonia 2
SI - Slovenia 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
BG - Bulgaria 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
EU - Europa 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
LV - Lettonia 1
MX - Messico 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 12.343
Salva come PNG Salva come JPEG
Città #
Fairfield 1.501
Woodbridge 1.241
Houston 871
Ann Arbor 827
Jacksonville 696
Chandler 690
Ashburn 603
Wilmington 573
Seattle 538
Cambridge 501
Princeton 252
Dong Ket 226
Padova 219
Roxbury 170
Medford 157
Beijing 132
San Diego 131
Nanjing 128
Helsinki 98
Des Moines 89
Guangzhou 63
Boardman 62
Milan 35
Shenyang 34
Venice 34
Norwalk 29
Nanchang 28
Mestre 27
Shanghai 27
Hebei 26
Munich 26
Jiaxing 20
Changsha 19
Dublin 18
Falls Church 16
New York 16
Tianjin 16
London 15
Chieti 14
Jinan 14
Senigallia 13
Hefei 12
Redwood City 12
Lappeenranta 11
Ankara 10
Cardiff 10
Los Angeles 9
Rome 9
Vicenza 9
Hounslow 8
Ogden 8
Tappahannock 8
Al `Atabah 7
Kharkiv 7
Malo 7
Ningbo 7
Bengaluru 6
Bologna 6
Borås 6
Hangzhou 6
Kunming 6
Paris 6
Torino 6
Indiana 5
Kolkata 5
Phoenix 5
Pune 5
Treviso 5
Central 4
Chengdu 4
Chicago 4
Eppelheim 4
Islamabad 4
Legnaro 4
Montreal 4
Monza 4
Palermo 4
Sahiwal 4
Saint Petersburg 4
Singapore 4
Taizhou 4
Toronto 4
Turin 4
Canelli 3
Detroit 3
Florence 3
Groningen 3
Haikou 3
Heredia 3
Leipzig 3
Napoli 3
Parma 3
Pisa 3
Portland 3
Prescot 3
Redmond 3
Riva Del Garda 3
Salamanca 3
San Francisco 3
Santa Giustina in Colle 3
Totale 10.507
Salva come PNG Salva come JPEG
Nome #
(1-B-D-arabinofuranosyl)cytosine (Ara-C) polymer conjugates for controlled release 177
Transgultaminase-Mediated Nanoarmoring of Enzymes by PEGylation 159
Site-selective enzymatic chemistry for polymer conjugation to protein lysine residues: PEGylation of G-CSF at lysine-41 154
Hyaluronic acid as a protein polymeric carrier: An overview and a report on human growth hormone 151
Chemical and Enzymatic Site Specific PEGylation of hGH: The Stability and in vivo Activity of PEG-N-Terminal-hGH and PEG-Gln141-hGH Conjugates 143
Drug and protein delivery by polymer conjugation 142
Role of proton pump inhibitor on esophageal carcinogenesis and pancreatic acinar cell metaplasia development: an experimental in vivo study. 135
A Non-Covalent Antibody Complex for the Delivery of anti-cancer drugs 132
Covalent conjugation of poly(ethylene glycol) to proteins and peptides: strategies and methods 131
Site-Specific Transglutaminase-Mediated Conjugation of Interferon α-2b at Glutamine or Lysine Residues 131
Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells 130
A new method to increase selectivity of transglutaminase mediated PEGylation of salmon calcitonin and human growth hormone 129
Nanomedicines for the Delivery of Biologics 125
Molecular platforms for targeted drug delivery 121
Novel Super Stealth immunoliposomes for cancer targeted delivery of doxorubicin: an innovative strategy to reduce liver toxicity 117
PEGILAZIONE INNOVATIVA DEL KILLER TNF-APOPTOSIS INDUCED LIGAND (KILLER-TRAIL) 116
Drug conjugation to hyaluronan widens therapeutic indications for ovarian cancer 116
Multivalent and Flexible PEG-Nitrilotriacetic Acid Derivatives for Non-covalent Protein Pegylation 111
Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccines 107
A new PEG-b-alanine active derivative for releasable protein conjugation 106
A site-selective hyaluronan-interferonα2a conjugate for the treatment of ovarian cancer 106
Overcoming Cancer Cell Drug Resistance by a Folic Acid Targeted Polymeric Conjugate of Buthionine Sulfoximine 104
Covalent immobilisation of transglutaminase: stability and applications in protein PEGylation 103
Abstract B192: The EPR effect of CDP-tubulysin in the recurrence of lung and pancreatic cancers 103
Dendritic Poly(ethylene glycol) Bearing Paclitaxel and Alendronate for Targeting Bone Neoplasms 102
Inulin-d-α-Tocopherol Succinate (INVITE) Nanomicelles as a Platform for Effective Intravenous Administration of Curcumin 101
PEGylation: Posttranslational bioengineering of protein biotherapeutics 100
Pegylation for improving the effectiveness of therapeutic biomolecules 99
Synthesis, characterization and preliminary cytotoxicity assays of poly(ethylene glycol)-malonato-Pt-DACH conjugates 99
Polyethylene glycols: An effective strategy for limiting liver ischemia reperfusion injury 98
Basic strategies for PEGylation of peptide and protein drugs 97
Chemical and Enzymatic Site Specific PEGylation of hGH 97
A Biodegradable Polymeric Carrier Based on PEG for Drug Delivery 96
Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy. 94
PEGylated proteins as cancer therapeutics 92
CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo 92
PEG-Ara-C conjugates for controlled release 91
PEG-epirubicin conjugates with high drug loading 88
A novel PEG-haloperidol conjugate with a non-degradable linker shows the feasibility of using polymer-drug conjugates in a non-prodrug fashion 88
Thiol-Activated Anticancer Agents: The State of the Art 86
Actin-Resistant DNase1L2 as a Potential Therapeutics for CF Lung Disease 86
Stabilization of a supplemental digestive enzyme by post-translational engineering using chemically-activated polyethylene glycol 85
PEG-doxorubicin conjugates: Influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity 85
PEG-metronidazole conjugates: synthesis, in vitro and in vivo properties 85
Polyethylene glycol and a novel developed polyethylene glycol-nitric oxide normalize arteriolar response and oxidative stress in ischemia-reperfusion 84
Polyoxazoline: chemistry, properties, and applications in drug delivery 82
State of the art in PEGylation: The great versatility achieved after forty years of research 80
PHEA-Graft-Polymethacrylate Supramolecular Aggregates for Protein Oral Delivery 80
Pegylation of Biological Molecules and Potential Benefits: Pharmacological Properties of Certolizumab Pegol 80
Super Stealth immunoliposomes as a strategy to overcome liposome-induced liver toxicity 80
Novel Monodisperse PEG-Dendrons as New Tools for Targeted Drug Delivery: Synthesis, Characterization and Cellular Uptake 79
Pharmacokinetic stability of macrocyclic peptide triazole HIV-1 inactivators alone and in liposomes 79
Transglutaminase and Sialyltransferase Enzymatic Approaches for Polymer Conjugation to Proteins 79
A rhabdomyosarcoma hydrogel model to unveil cell-extracellular matrix interactions 79
PEGylation, successful approach to drug delivery. 76
Polymer-Drug Conjugates for Combination Anticancer Therapy: Investigating the Mechanism of Action 76
Selective conjugation of poly(2-ethyl 2-oxazoline) to granulocyte colony stimulating factor 76
Conjugation of hyaluronan to proteins 76
Protein PEGylation, basic science and biological applications 75
PEG conjugates in clinical development or use as anticancer agents: an overview 75
PEGylated α Interferons: two different strategies to achieve increased efficacy 75
Poly(L-glutamic acid)-co-poly(ethylene glycol) block copolymers for protein conjugation 75
Antitumoral activity of peg-gemcitabine prodrugs targeted by folic acid 74
Polymers for Protein Conjugation 74
Detection of sites of infection in mice using 99mTc-labeled PN(2)S-PEG conjugated to UBI and 99mTc-UBI: a comparative biodistribution study. 74
Peritoneal tumor carcinomatosis: pharmacological targeting with hyaluronan-based bioconjugates overcomes therapeutic indications of current drugs. 74
The Protein Engineering Approach Differentiates the Functional Importance of Carbohydrate Moieties of Interleukin-5 Receptor α 74
Poly(ethylene glycol)-mesalazine conjugate for colon specific delivery. 73
Improvement of Drug Therapy by Covalent PEG Conjugation: An Overview From a Research Laboratory 73
Synthesis and characterization of poly(2-ethyl 2 oxazoline)-conjugates with proteins and drugs: suitable alternatives to PEG-conjugates? 72
Polysialic acid as a drug carrier: evaluation of a new polysialic acid–epirubicin conjugate and its comparison against established drug carriers 72
Poly(ethylene glycol)–paclitaxel–alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases 72
Protective Effect of Intravenous High Molecular Weight Polyethylene Glycol on Fatty Liver Preservation 72
Recent Developments in Hyaluronic Acid-Based Nanomedicine 72
NEW PEGYLATED CHELATING AGENT (mPEG-PN2S) SHOWED AN EASY LABELING METHOD WITH 99mTECHNETIUM USEFUL FOR TUMOUR DIAGNOSIS 71
Site-Specific Pegylation of G-CSF by Reversible Denaturation 71
Peg-doxorubicin conjugates with high loading 71
99mTechnetium labeling of pegylated PN2S ligand in presence or absence of tin (II) 71
A novel HER2-targeted liposomal formulation for reducing the risk of liposome-induced hepatotoxicity 71
Novel PEG conjugates releasing nitric oxide: preparation and activity against oxidative stress in ischemia reperfusion injury 70
A novel PEG-chelating agent conjugate for protein delivery 70
Development of a new hyaluronic acid-calcitonin conjugate for the local treatment of osteoarthritis 70
Poly(ethylene glycol)-protein, peptide and enzyme conjugates 69
PEGylation of proteins as tailored chemistry for optimized bioconjugates 69
Liver graft washout prevents against reperfusion Injury: protective effects on glycocalyx and cytoskeleton 69
A hyaluronic acid-salmon calcitonin conjugate for the local treatment of osteoarthritis: Chondro-protective effect in a rabbit model of early OA 68
Polyethylene glycol rinse solution: An effective way to prevent ischemia-reperfusion injury. 67
Kinetic Interaction Analysis of Human Interleukin 5 Receptor α Mutants Reveals a Unique Binding Topology and Charge Distribution for Cytokine Recognition 66
Relevance of folic acid/polymer ratio in targeted PEG-epirubicin conjugates 66
New active poly(ethylene glycol) derivative for amino coupling 65
Polyethylene glycol-based linkers as hydrophilicity reservoir for antibody-drug conjugates 65
Indirect 99mTc-labeled UBI Using PN2S-PEG Moiety 64
Process for the synthesis of conjugates of glycosaminoglycanes (GAG) with biologically active molecules, polymeric conjugates and relative uses thereof 63
Farmacodinamica dei farmaci biologici 63
Highly efficient technetium-99m labeling procedure based on the conjugation of N-[N-(3-diphenylphosphinopropionyl)glycyl]cysteine ligand with poly(ethylene glycol) 62
PEG: an useful technology in anticancer therapy 60
A new high loading PEG fro drug release 59
Active poly(ethylene glycol) carbamate for protein modification 59
POLYETHYLENE GLYCOL PRECONDITIONING: AN EFFECTIVE STRATEGY TO PREVENT LIVER ISCHEMIA REPERFUSION INJURY 59
Kinetic Interaction Analysis of Human Interleukin 5 Receptor á Mutants Reveals a Unique Mechanism of Cytokine Recognition in the Class I Cytokine Receptor Family 58
Totale 8.908
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.230
article - articoli 26.735
book - libri 239
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 1.383
selected - selezionate 0
volume - volumi 4.975
Totale 75.562
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019612 0 0 0 0 0 0 0 0 0 0 331 281
2019/20202.449 353 78 27 246 228 194 261 271 254 262 138 137
2020/20212.090 100 161 58 159 50 126 48 215 313 229 261 370
2021/20222.344 70 303 292 103 117 97 134 312 102 34 237 543
2022/20231.579 380 106 41 143 274 207 19 103 181 19 71 35
2023/2024838 63 160 100 86 60 56 78 50 64 116 5 0
Totale 12.465